Not recruiting
Primary biliary cholangitis+1
Not recruitingStudy on Long-term Safety of Linerixibat for Treating Itchy Skin in Patients with Primary Biliary Cholangitis
InvestigationalNo placebo
Study on Long-term Safety of Linerixibat for Treating Itchy Skin in Patients with Primary Biliary Cholangitis
InvestigationalNo placebo
- Disease:Primary biliary cholangitisCholestatic pruritus
- Substances:Linerixibat
Countries:
Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:Linerixibat
- Sponsor:Glaxosmithkline Research & Development Limited






